Top Markets
Coin of the day
Hancock Jaffe Laboratories Hancock Jaffe Laboratories

Hancock Jaffe Laboratories

HJLI
Hisse Senetlerindeki Sıralama #35033
Hancock Jaffe Laboratories, Inc. is a medical device company in its... Hancock Jaffe Laboratories, Inc. is a medical device company in its developmental stage, specializing in creating advanced tissue-based and biologic solutions. These innovations are engineered to either sustain or significantly enhance the lives of patients afflicted with cardiovascular, peripheral arterial, and venous diseases, as well as end-stage renal disease (ESRD). The firm, headquartered in Irvine, California, maintains a dedicated team of nine full-time employees. Among its key initiatives, the company is actively developing implantable bioprosthetic devices for cardiovascular applications. This includes the Bioprosthetic Heart Valve (BHV), a swine-derived heart valve designed to mimic the function of a native heart valve and provide superior performance compared to current prosthetic options. Furthermore, the company is developing a Venous Valve, another bioprosthetic device sourced from pig tissue. This valve is specifically designed for individuals suffering from chronic venous insufficiency (CVI) in the lower limbs, a condition frequently resulting from damage to leg vein valves after the formation of deep venous blood clots.
Hisse Fiyatı
$10.38
Son senkronizasyon: 2021-09-30
Piyasa Değeri
$4.55M
Değişim (1 gün)
-1.98%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Hancock Jaffe Laboratories (HJLI)

Kategori

Hancock Jaffe Laboratories (HJLI) için EPS
2026 itibariyle EPS TTM: 0
Hancock Jaffe Laboratories şirketinin en son finansal raporlarına ve hisse senedi fiyatına göre, şirketin mevcut EPS'si (TTM) 0'dir. 2026 yılı sonunda, şirketin EPS'si 0 idi; bu, 2026 yılındaki EPS olan 0 ile önceki yıla eşit.
Hancock Jaffe Laboratories için 2026 - 2026 arasındaki EPS geçmişi
Her yıl sonunda EPS
Yıl EPS Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için EPS